Safety and efficacy of eltrombopag in patients with aplastic anemia: a systematic review and meta-analysis of randomized controlled trials

CONCLUSION: Compared to immunosuppressive therapy alone, eltrombopag combined with immunosuppressive therapy showed significant improvements in 6-month CR and 6-month OR. However, it also resulted in increased pigment deposition and abnormal liver function in terms of safety.PMID:38553907 | DOI:10.1080/16078454.2024.2335419

Source: Hematology - March 30, 2024 Category: Hematology Authors: Huaipeng Guo Cangchun Liu Lei Kang Cong Liu Ying Liu Source Type: research